
UNH
- Market cap
- $472B
- Sector
- Health care

Stored run, base case: $741.34 · difference under 0.1%.
Value per share against today's price
The multiple the final year is sold at
Higher means a lower value
A year, for 10 years held
Sensitivity: discount rate × exit multiple
Value per share at each pairing. The outlined cell is the pairing the rail is set to.
| Exit multiple → | |||||
|---|---|---|---|---|---|
| Discount rate | 16.3× | 17.3× | 18.3× | 19.3× | 20.3× |
| 6.00% | $741.34 | $774.80 | $808.26 | $841.72 | $875.18 |
| 6.50% | $710.14 | $742.06 | $773.98 | $805.91 | $837.83 |
| 7.00% | $680.42 | $710.88 | $741.34 | $771.81 | $802.27 |
| 7.50% | $652.11 | $681.18 | $710.25 | $739.33 | $768.40 |
| 8.00% | $625.12 | $652.88 | $680.63 | $708.39 | $736.14 |
Both axes step around the rail's own settings, so the grid re-centres whenever you move one.
Exit multiple vs historical EV / EBITDA
Exit multiple 18.3× vs the company's own multiple by fiscal year, oldest first.
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Company EV / EBITDA | 23.3× | 21.0× | 18.1× | 16.0× | 13.9× |
| Exit 18.3× vs it | −21% | −13% | +1% | +15% | +31% |
Implied perpetual growth at 18.3×: 3.27%
The growth for ever, after year 10, at which the final year's free cash flow to the firm, discounted at 7.00%, is worth what the sale fetches.
A rate near 2–3% is usually read as consistent with a mature business. Well above it, the multiple carries growth the forecast itself stops short of.
Valuation build-up
Dollars per share: the enterprise figures divided by the share count.
| Per share | Share | Amount |
|---|---|---|
| EBITDA per share, current | $40.52 | |
| EBITDA per share, year 10 | $59.95 | |
| PV of exit value at 18.3× | 75% | $557.70 |
| PV of interim free cash flow to the firm | 32% | $235.82 |
| Less: net debt per share | $52.17 | |
| Value per share | $741.34 |
Methodology
Ten years of EBITDA, sold at an exit multiple, with free cash flow to the firm credited along the way and the debt subtracted at the end.
| Construction | Recorded |
|---|---|
| EBITDA in 2036 | $55.2B |
| Multiple applied | 18.3× |
| Supported multiple range | 11.5× to 22.9×, median 18.3× |
| Holding period | 10 years |
| Phase-2 start | year 6 |
| Discount rate (WACC) | 7.00% |
| Less: net debt per share | $52.17 |
| Value per share | $757.02 |
Scenarios and weights
Dollars per share. Each case moves the growth path and the multiple together, because a slower business sells for less.
| Case | Weight | Growth | Then | Sold at | Value per share | vs price |
|---|---|---|---|---|---|---|
| Negative | 20% | 1.8% | 1.1% | 15.6× | +1.4% | |
| Base | 60% | 5.0% | 3.0% | 18.3× | +44.6% | |
| Optimistic | 20% | 8.2% | 4.9% | 21.1× | +103.1% |
Weighted answer $757.02, which is the figure on this card.
Multiple rationale
Its own five-year average is 22.9× and the sector median is 11.5×; the choice sits at 18.3×, three parts the first and two parts the second. The size-ranked comparables run from 9.2× to 29.4× and set nothing here. Applied to EBITDA in 2036, discounted once at 7.0%.
Its own five-year average and the sector median are the two benchmarks the relative-valuation tab publishes for the same ratio.
Size-matched comparables
Context only. None of these enters the multiple above.
| Company | Multiple | vs applied |
|---|---|---|
| JPM JPMorgan | −50% | |
| GE GE Aerospace | +19% | |
| INTU Intuit | +60% |